|
Match
|
Document |
Document Title |
|
|
US20110250153 |
OLIGOMERIC BIOSURFACTANTS IN DERMATOCOSMETIC COMPOSITIONS
Oligomeric acylated biosurfactants (“OABs”) having low critical micelle concentrations of from about 1.0 ppm to about 200 ppm, preferably less than about 50 ppm, in an aqueous solution of Minimal... |
|
|
US20140121172 |
FORMULATIONS CONTAINING LABELS FOR MEDICAL DIAGNOSTICS
Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional... |
|
|
US20130287756 |
COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other... |
|
|
US20110020316 |
COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other... |
|
|
US20120128762 |
Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to... |
|
|
US20110212157 |
DERMAL DELIVERY
The present invention describes systems and methods for treating disorders and/or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis,... |
|
|
US20150110718 |
METHODS AND KITS FOR DETERMINING A PLACEBO PROFILE IN SUBJECTS FOR CLINICAL TRIALS AND FOR TREATMENT OF PATIENTS
The present invention is directed to methods and assays for identifying subjects participating in clinical trials that may exhibit a placebo response and identifying treatments for subjects with... |
|
|
US20110028382 |
TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA
The invention provides compounds for use in a method of treating oral pharyngeal dysphagia in an individual and related products. One embodiment of the invention comprises administering to an... |
|
|
US20110152205 |
APPLICATION OF PUERARIN IN THE PREPARATION OF P2X3 MEDIATED DRUGS FOR PAIN/NERVOUS SYSTEM DISEASES
The invention relates to the new usage of puerarin in the field of pharmaceutical products, in other words, it relates to the application of puerarin in the preparation of drugs for P2X3 mediated... |
|
|
US20140323391 |
BIOMARKERS FOR THE MOLECULAR CLASSIFICATION OF BACTERIAL INFECTION
Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject. |
|
|
US20140274913 |
METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN
Compositions and methods for treating, reducing, or preventing a disease or symptom such as gingivitis, periodontitis, gastritis, colitis, ileitis, Crohn's disease, chronic inflammatory intestinal... |
|
|
US20130022661 |
BIO-REMODABLE BONE AUGMENTATION DEVICE AND METHOD
A bio-remodable augmentation device including an implantable member configured for maintaining space in a bone defect. The implantable member is formed from a bio-remodable composite having... |
|
|
US20120202753 |
INHIBITING INFLAMMATION WITH MILK OLIGOSACCHARIDES
A method of inhibiting inflammation in a subject comprising the administration of milk oligosaccharides or glycoconjugates containing milk oligosaccharides is disclosed. |
|
|
US20110104228 |
SELF-ELIMINATING COATINGS
The invention features the use of a matrix consisting of low molecular weight components for use as a self-eliminating coating for implantable medical devices. The matrix coatings can be used to... |
|
|
US20120244222 |
OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
This invention relates, at least in part, to osmotic mediated release barrier-free synthetic nanocarriers and methods of production and use. |
|
|
US20150133366 |
COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION
C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic therapy remains as the standard treatment for this antibiotic-induced disease and... |
|
|
US20110311442 |
DIRECT CELLULAR ENERGY DELIVERY SYSTEM
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group... |
|
|
US20130059802 |
BORON-CONTAINING SMALL MOLECULES
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to... |
|
|
US20120010160 |
Rapidly Dissolving Oral Strip of Sugar for Hypoglycemia
A method of orally administering measured doses of sugar into the bloodstream for controlling glucose levels, particularly for those individuals with diabetes or those who experience difficulty... |
|
|
US20140100174 |
Treatment for Cancer
Treatment for Cancer Using A Preparation containing a combination of one or more Natural or Synthetic or a Combination of Natural and Synthetic Boswellic Acids and one or more Natural or Synthetic... |
|
|
US20110098238 |
ELUCIDATING LIGAND-BINDING INFORMATION BASED ON PROTEIN TEMPLATES
A method, computer-readable medium, and system for identifying compounds from chemical libraries that can be used for the therapeutic treatment of a disease or used as lead compounds in a drug... |
|
|
US20150065438 |
PREPACKAGED STERILE SYRINGE OR CONTAINERS WITH VARIOUS SUBSTANCE CONCENTRATIONS WITH OR WITHOUT BIOACTIVE REAGENT
A prepackaged sterile syringe or bottle with various concentrations of tissue and organ biologically stimulating reagents i.e., dextrose, various anthocyanins, anthocyanidins and/or their various... |
|
|
US20120058099 |
USE OF HYPOXANTHINE FOR PROMOTION OF NEURONAL OUTGROWTH
Disclosed herein is a method of promoting neuronal outgrowth in a neuron. The method comprises contacting the neuron with an effective amount of hypoxanthine, to thereby promote neuronal outgrowth... |
|
|
US20140162964 |
USE IN BRAIN DEGENERATIVE DISEASES
Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in the treatment of progressive dementia or brain degenerative diseases. |
|
|
US20110053889 |
Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
A method for determining the effect of critical glyconutrient dietary supplements in premature and term infants on growth, health, and brain function during early childhood development is... |
|
|
US20120010162 |
METHOD FOR TREATMENT OF LUNG INFECTIONS BY ADMINISTRATION OF AMINOGLYCOSIDES BY AEROLISATION
The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in... |
|
|
US20120101427 |
NOVEL PHOTOSENSITIZER FORMULATIONS FOR ORAL ADMINISTRATION
The present invention provides novel drug formulations for oral administration for diverse medical applications including anticancer, antimetastatic, antibacterial, antifungal, antiprotozoic,... |
|
|
US20060241058 |
Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
Acetyl L-carnitine, or of one of its pharmaceutically acceptable salts, is useful for the prevention of painful peripheral neuropathy in patients suffering from type 2 diabetes, in which symptoms... |
|
|
US20110183927 |
Compositions Comprising Sugar-Cysteine Products
The present invention provides compositions comprising sugar, cysteine, and/or sugar-cysteine products, methods of preparing the same, and/or using the same. |
|
|
US20110311478 |
Combinatorial Methods For Treating Cellular Proliferative Disorders And Immune Deficiencies Using Salicinium
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become... |
|
|
US20120328523 |
POLYHYDROXYALKANOATES FOR IN VIVO APPLICATIONS
Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify... |
|
|
US20120114776 |
METHODS FOR PREPARING PROBIOTIC NANOPARTICLES
Various embodiments of the present invention are directed toward a method for preparing probiotic nanoparticles from natural sources, comprising performing a biological preparation phase such as... |
|
|
US20110059906 |
Energy status of an individual by enhanced production of an endogenous fuel source
The present invention relates to a method of improving the energy status of an individual by enhancing the usage of lactate. Improved lactate usage is accomplished through a composition comprising... |
|
|
US20130064884 |
COMPOSITION AND METHOD FOR TREATING KETOSIS IN COWS
A method for prophylactic treatment of ketosis in a calving cow, the method including orally administering to the cow within a time period of about 12 hours after calving an effective dose of from... |
|
|
US20150011485 |
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is... |
|
|
US20110009347 |
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is... |
|
|
US20110293681 |
HAND SANITIZING PATCH HAVING AN INTEGRALLY BONDED ANTIMICROBIAL
The present invention provides for topical adhesive patch that includes a backing having a front side and a back side; a formulation in contact with the front side of the backing, the formulation... |
|
|
US20130183281 |
METHODS AND COMPOSITONS FOR CELL-PROLIFERATION-RELATED DISORDERS
Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2). |
|
|
US20090291877 |
TREATMENTS USING CITRULLINE
The invention provides a method and formulation for the treatment or maintenance of conditions that would be benefited from increasing or maintaining Arginine levels in the blood, and having... |
|
|
US20120058186 |
THERAPEUTIC OR PROPHYLACTIC AGENT FOR DYSKINESIA
The present invention relates to a stable orally disintegrating coated tablet containing a drug, wherein the tablet is coated with a coating layer containing a water-soluble substance and a... |
|
|
US20140243261 |
Method for treating diabetes and fatty liver disese by stimulating cellular metabolism
The present invention is a method of treating various diseases and conditions through administering a substantial caloric load coupled with administration of hormone to stimulate the body to... |
|
|
US20110002881 |
TREATMENT AND PROPHYLAXIS
This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present... |
|
|
US20130084311 |
Lingual Vestibular Dosage-form and Delivery System for Transmucosal Administration of Pharmaceutical Agents
A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the... |
|
|
US20110301103 |
Methods of Treatment
The present disclosure provides a biochemical basis of nephrotic syndrome and provides and explanation for the observed proteinuria and other effects. As a result, the present disclosure provides... |
|
|
US20120087980 |
STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES
Flavonoid glycosides, such as isoquercitrin, are shown to stimulate the formation of neuritis and neuronal synapses in neurons and neuronal progenitor (stem) cells. |
|
|
US20130337055 |
COMPOSITIONS, METHODS OF TREATMENT AND DIAGNOSTICS FOR TREATMENT OF HEPATIC STEATOSIS ALONE OR IN COMBINATION WITH A HEPATITIS C VIRUS INFECTION
The present invention is directed to pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of an array of the manifestations of metabolic... |
|
|
US20140005099 |
MARKERS FOR DIAGNOSIS OF PULMONARY INFLAMMATION AND METHODS RELATED THERETO
The present invention is related to the novel discovery of a number of genes that were identified as systemic markers of pulmonary inflammation. This discovery allows for development of a novel... |
|
|
US20140303067 |
TREATMENT OF EOSINOPHILIC ESOPHAGITIS
The present invention provides a method for the treatment of eosinophilicesophagitis comprising administering non-digestible oligosaccharides. |
|
|
US20110046083 |
ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASE
The invention described herein features methods, compositions, and kits for the use of activators of PKM2 for the treatment, prevention, or amelioration of diseases related to PKM2 function,... |
|
|
US20070117762 |
Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunction
Erectile dysfunction is treated with a combination of propionyl L-carnitine in combination with sildenafil, apomorphine prostaglandin E1, pentolamine and papaverine. |